'Abstract' First-line Chemotherapy (FLC) Regimens in Older Adults (>65 years old) with Metastatic HER2-negative Breast Cancer (MBC): a Single-centre Experience of Tolerability and Efficacy

Timothy Robinson

doi:10.1016/j.clon.2019.03.040

'Abstract' First-line Chemotherapy (FLC) Regimens in Older Adults (>65 years old) with Metastatic HER2-negative Breast Cancer (MBC): a Single-centre Experience of Tolerability and Efficacy

Research output: Contribution to journal › Article (Academic Journal) › peer-review

Original language	English
Journal	Clinical Oncology
Early online date	6 Jun 2019
DOIs	https://doi.org/10.1016/j.clon.2019.03.040
Publication status	Published - Jul 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clon.2019.03.040

Handle.net

Persistent link

Cite this

@article{b64173e6e91f4eef9c436fe4e64761c0,

title = "'Abstract' First-line Chemotherapy (FLC) Regimens in Older Adults (>65 years old) with Metastatic HER2-negative Breast Cancer (MBC): a Single-centre Experience of Tolerability and Efficacy",

author = "Timothy Robinson",

year = "2019",

month = jul,

doi = "10.1016/j.clon.2019.03.040",

language = "English",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "W.B. Saunders",

}

TY - JOUR

T1 - 'Abstract' First-line Chemotherapy (FLC) Regimens in Older Adults (>65 years old) with Metastatic HER2-negative Breast Cancer (MBC)

T2 - a Single-centre Experience of Tolerability and Efficacy

AU - Robinson, Timothy

PY - 2019/7

Y1 - 2019/7

U2 - 10.1016/j.clon.2019.03.040

DO - 10.1016/j.clon.2019.03.040

M3 - Article (Academic Journal)

SN - 0936-6555

JO - Clinical Oncology

JF - Clinical Oncology

ER -